Exacerbation recovery patterns in newly diagnosed or maintenance treatment-naïve patients with COPD: secondary analyses of TICARI 1 trial data

References

• MapelDWDalalAABlanchetteCMPetersenHFergusonGTSeverity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claimsInt J Chron Obstruct Pulmon Dis2011657358122135490
   PubMed Web of Science ®Google Scholar
• DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
   PubMed Web of Science ®Google Scholar
• DonaldsonGCSeemungalTAPatelISLloyd-OwenSJWilkinsonTMWedzichaJALongitudinal changes in the nature, severity and frequency of COPD exacerbationsEur Respir J200322693193614680081
   PubMed Web of Science ®Google Scholar
• HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
   PubMed Web of Science ®Google Scholar
• VestboJEdwardsLDScanlonPDChanges in forced expiratory volume in 1 second over time in COPDN Engl J Med2011365131184119221991892
   PubMed Web of Science ®Google Scholar
• SeemungalTADonaldsonGCBhowmikAJeffriesDJWedzichaJATime course and recovery of exacerbations in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200016151608161310806163
   PubMed Web of Science ®Google Scholar
• AaronSDDonaldsonGCWhitmoreGAHurstJRRamsayTWedzichaJATime course and pattern of COPD exacerbation onsetThorax201267323824322008189
   PubMed Web of Science ®Google Scholar
• NiewoehnerDERiceKCoteCPrevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trialAnn Intern Med2005143531732616144890
   PubMed Web of Science ®Google Scholar
• TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
   PubMed Web of Science ®Google Scholar
• HalpinDMenjogeSVielKPatient-level pooled analysis of the effect of tiotropium on COPD exacerbations and related hospitalisationsPrim Care Respir J200918210611319407916
   PubMedGoogle Scholar
• DecramerMCelliBKestenSLystigTMehraSTashkinDPEffect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trialLancet200937496961171117819716598
   PubMed Web of Science ®Google Scholar
• TroostersTCelliBLystigTTiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trialEur Respir J2010361657320185426
   PubMed Web of Science ®Google Scholar
• VogelmeierCHedererBGlaabTTiotropium versus salmeterol for the prevention of exacerbations of COPDN Engl J Med2011364121093110321428765
   PubMed Web of Science ®Google Scholar
• MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
   PubMed Web of Science ®Google Scholar
• QuanjerPHTammelingGJCotesJEPedersenOFPeslinRYernaultJCLung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory SocietyEur Respir J Suppl1993165408499054
   PubMedGoogle Scholar
• PellegrinoRViegiGBrusascoVInterpretative strategies for lung function testsEur Respir J200526594896816264058
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD)Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease2010Accessed June 22, 2017 Available from: http://www.goldcopd.org
   Google Scholar
• LeidyNKWilcoxTKJonesPWRobertsLPowersJHSethiSStandardizing measurement of chronic obstructive pulmonary disease exacerbations. Reliability and validity of a patient-reported diaryAm J Respir Crit Care Med2011183332332920813886
   PubMed Web of Science ®Google Scholar
• LeidyNKMurrayLTJonesPSethiSPerformance of the EXAc-erbations of chronic pulmonary disease tool patient-reported outcome measure in three clinical trials of chronic obstructive pulmonary diseaseAnn Am Thorac Soc201411331632524432712
   PubMedGoogle Scholar
• JonesPWHardingGBerryPWiklundIChenWHKline LeidyNDevelopment and first validation of the COPD Assessment TestEur Respir J200934364865419720809
   PubMed Web of Science ®Google Scholar
• YountSEChoiSWVictorsonDBrief, valid measures of dyspnea and related functional limitations in chronic obstructive pulmonary disease (COPD)Value Health201114230731521402298
   PubMed Web of Science ®Google Scholar
• ReillyMCZbrozekASDukesEMThe validity and reproducibility of a work productivity and activity impairment instrumentPharmacoeconomics19934535336510146874
   PubMed Web of Science ®Google Scholar
• KonSSCanavanJLJonesSEMinimum clinically important difference for the COPD assessment test: a prospective analysisLancet Respir Med20142319520324621681
   PubMed Web of Science ®Google Scholar
• BeauchesneMFJulienMJulienLAAntibiotics used in the ambulatory management of acute COPD exacerbationsInt J Chron Obstruct Pulmon Dis20083231932218686741
   PubMedGoogle Scholar
• MiravitllesMExacerbations of chronic obstructive pulmonary disease: when are bacteria important?Eur Respir J Suppl2002369s19s12168752
   PubMedGoogle Scholar
• PereraWRHurstJRWilkinsonTMInflammatory changes, recovery and recurrence at COPD exacerbationEur Respir J200729352753417107990
   PubMed Web of Science ®Google Scholar
• HurstJRDonaldsonGCQuintJKGoldringJJBaghai-RavaryRWedzichaJATemporal clustering of exacerbations in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2009179536937419074596
   PubMed Web of Science ®Google Scholar
• MüllerováHShuklaAHawkinsAQuintJRisk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort studyBMJ Open2014412e006171
   PubMed Web of Science ®Google Scholar
• BarnesNCalverleyPMKaplanARabeKFChronic obstructive pulmonary disease and exacerbations: patient insights from the global Hidden Depths of COPD surveyBMC Pulm Med2013135423971625
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD)Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease2017Accessed March 16, 2018 Available from: http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/
   Google Scholar
• QureshiHSharafkhanehAHananiaNAChronic obstructive pulmonary disease exacerbations: latest evidence and clinical implicationsTher Adv Chronic Dis20145521222725177479
   PubMedGoogle Scholar
• TroostersTSciurbaFCDecramerMTiotropium in patients with moderate COPD naive to maintenance therapy: a randomised placebo-controlled trialNPJ Prim Care Respir Med2014241400324841833
   PubMed Web of Science ®Google Scholar
• VogelmeierCFabbriLMRabeKFEffect of tiotropium vs. salmeterol on exacerbations: GOLD II and maintenance therapy naive patientsRespir Med20131071758323102611
   PubMed Web of Science ®Google Scholar
• BarnesNCQiuYSPavordIDAntiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung diseaseAm J Respir Crit Care Med2006173773674316424444
   PubMed Web of Science ®Google Scholar
• DecramerMLChapmanKRDahlROnce-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group studyLancet Respir Med20131752453324461613
   PubMed Web of Science ®Google Scholar
• WedzichaJACalverleyPMSeemungalTAHaganGAnsariZStockleyRAThe prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromideAm J Respir Crit Care Med20081771192617916806
   PubMed Web of Science ®Google Scholar
• WedzichaJADecramerMSeemungalTAThe role of bronchodilator treatment in the prevention of exacerbations of COPDEur Respir J20124061545155422835613
   PubMed Web of Science ®Google Scholar